Is a mass immunization program for pandemic (H1N1) 2009 good value for money? Evidence from the Canadian Experience.
In response to the pandemic H1N1 influenza 2009 outbreak, many jurisdictions undertook mass immunization programs that were among the largest in recent history. The objective of this study was to determine the cost-effectiveness of the mass H1N1 immunization program in Ontario, Canada's most populous province (population 13,000,000). This analysis suggests that a mass immunization program as carried out in Ontario and many other high-income health care systems in response to H1N1 2009 was effective in preventing influenza cases and health care resource use and was also highly cost-effective despite the substantial program cost.
Sander
Beate
B
Department of Health Policy, Management and Evaluation, University of Toronto, Toronto, Canada. beate.sander@oahpp.ca
Bauch
Chris T
CT
Fisman
David
D
Fowler
Robert A
RA
Kwong
Jeffrey C
JC
Maetzel
Andreas
A
McGeer
Allison
A
Raboud
Janet
J
Scales
Damon C
DC
Gojovic
Marija Zivkovic
MZ
Krahn
Murray
M
D003362:Cost-Benefit Analysis; D004196:Disease Outbreaks / Q000517:prevention & control*; D006801:Humans; D053118:Influenza A Virus, H1N1 Subtype; D007252:Influenza Vaccines / Q000191:economics*; D007251:Influenza, Human / Q000517:prevention & control*; D032541:Mass Vaccination / Q000191:economics*; D018803:Models, Economic; D009864:Ontario; D012680:Sensitivity and Specificity
D007252:Influenza Vaccines